KR20220128611A - 맥락적 희귀 코돈용 trem 조성물 및 관련 용도 - Google Patents
맥락적 희귀 코돈용 trem 조성물 및 관련 용도 Download PDFInfo
- Publication number
- KR20220128611A KR20220128611A KR1020227018837A KR20227018837A KR20220128611A KR 20220128611 A KR20220128611 A KR 20220128611A KR 1020227018837 A KR1020227018837 A KR 1020227018837A KR 20227018837 A KR20227018837 A KR 20227018837A KR 20220128611 A KR20220128611 A KR 20220128611A
- Authority
- KR
- South Korea
- Prior art keywords
- trem
- contextually
- fragment
- seq
- codon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962930361P | 2019-11-04 | 2019-11-04 | |
| US62/930,361 | 2019-11-04 | ||
| PCT/US2020/058948 WO2021092064A1 (en) | 2019-11-04 | 2020-11-04 | Trem compositions for con-rare codons and related uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220128611A true KR20220128611A (ko) | 2022-09-21 |
Family
ID=73654885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227018837A Pending KR20220128611A (ko) | 2019-11-04 | 2020-11-04 | 맥락적 희귀 코돈용 trem 조성물 및 관련 용도 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220364092A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4055163A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023500116A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20220128611A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115003810A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020379762A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3160097A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2022005362A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021092064A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020004587A (es) | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| US20230203510A1 (en) * | 2020-05-29 | 2023-06-29 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods relating thereto |
| EP4158032A2 (en) * | 2020-05-29 | 2023-04-05 | Flagship Pioneering Innovations VI, LLC | Trem compositions and methods relating thereto |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20080318884A1 (en) * | 2005-03-25 | 2008-12-25 | The Uab Research Foundation | Methods for Altering Gene Expression and Methods of Treatment Utilizing Same |
| GB0600948D0 (en) * | 2006-01-18 | 2006-02-22 | Univ Dundee | Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders |
| WO2010141851A1 (en) * | 2009-06-05 | 2010-12-09 | Salk Institute For Biological Studies | Improving unnatural amino acid incorporation in eukaryotic cells |
| US9676810B2 (en) * | 2010-07-08 | 2017-06-13 | The Brigham And Women's Hospital, Inc. | Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| KR102485491B1 (ko) * | 2012-10-02 | 2023-01-04 | 벡션 테라퓨틱스 엘엘씨 | 면역 조절성 미니세포 및 사용 방법 |
| BR112016011195A2 (pt) | 2013-11-18 | 2017-09-19 | Rubius Therapeutics Inc | Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico |
| CN106456744A (zh) | 2014-04-01 | 2017-02-22 | 鲁比厄斯治疗法股份有限公司 | 用于免疫调节的方法和组合物 |
| WO2016183482A1 (en) | 2015-05-13 | 2016-11-17 | Rubius Therapeutics, Inc. | Membrane-receiver complex therapeutics |
| CN108697733A (zh) | 2016-01-11 | 2018-10-23 | 鲁比厄斯治疗法股份有限公司 | 与癌症适应症的多模式治疗性细胞体系有关的组合物和方法 |
| MX2019000205A (es) | 2016-07-07 | 2019-09-23 | Rubius Therapeutics Inc | Composiciones y metodos relacionados con sistemas celulares terapeuticos que expresan arn exogeno. |
| BR112019011138A2 (pt) | 2016-12-02 | 2019-10-01 | Rubius Therapeutics, Inc. | composições e métodos relacionados com sistemas celulares para penetração em tumores sólidos |
| CN110520522A (zh) | 2017-02-17 | 2019-11-29 | 鲁比厄斯治疗法股份有限公司 | 功能化红系细胞 |
| US11576872B2 (en) | 2017-05-08 | 2023-02-14 | Flagship Pioneering Innovations V, Inc. | Compositions for facilitating membrane fusion and uses thereof |
| EA202190736A1 (ru) * | 2018-09-26 | 2021-09-16 | Кейс Вестерн Ризерв Юниверсити | Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью |
| IL284878B2 (en) * | 2019-01-18 | 2026-04-01 | Flagship Pioneering Inc | TREM preparations and their uses |
| JP2022534988A (ja) * | 2019-05-31 | 2022-08-04 | フラッグシップ パイオニアリング, インコーポレイテッド | tRNAプールを調節するためのTREMの使用 |
-
2020
- 2020-11-04 CA CA3160097A patent/CA3160097A1/en active Pending
- 2020-11-04 MX MX2022005362A patent/MX2022005362A/es unknown
- 2020-11-04 JP JP2022525706A patent/JP2023500116A/ja active Pending
- 2020-11-04 EP EP20817113.2A patent/EP4055163A1/en active Pending
- 2020-11-04 WO PCT/US2020/058948 patent/WO2021092064A1/en not_active Ceased
- 2020-11-04 US US17/774,410 patent/US20220364092A1/en active Pending
- 2020-11-04 KR KR1020227018837A patent/KR20220128611A/ko active Pending
- 2020-11-04 CN CN202080077056.0A patent/CN115003810A/zh active Pending
- 2020-11-04 AU AU2020379762A patent/AU2020379762A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020379762A1 (en) | 2022-05-26 |
| CA3160097A1 (en) | 2021-05-14 |
| EP4055163A1 (en) | 2022-09-14 |
| CN115003810A (zh) | 2022-09-02 |
| US20220364092A1 (en) | 2022-11-17 |
| MX2022005362A (es) | 2022-09-23 |
| JP2023500116A (ja) | 2023-01-04 |
| WO2021092064A1 (en) | 2021-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220112489A1 (en) | Trem compositions and uses thereof | |
| EP3976782A1 (en) | Uses of trem compositions to modulate trna pools | |
| JP5291129B2 (ja) | 細胞および/または組織および/または疾患フェーズ特異的な薬剤の製造方法 | |
| JP2021500863A (ja) | ゲノム編集用のポリヌクレオチド、組成物および方法 | |
| US20220364092A1 (en) | Trem compositions for con-rare codons and related uses | |
| TW202102529A (zh) | 用於多肽表現之多核苷酸、組合物及方法 | |
| AU2022382975A1 (en) | Polynucleotides, compositions, and methods for genome editing | |
| JP2024506016A (ja) | 免疫療法のためのt細胞免疫グロブリン及びムチンドメイン3(tim3)組成物及び方法 | |
| JP2023534304A (ja) | Line1の阻害剤及びその使用 | |
| JP2025524456A (ja) | B2m発現のエピジェネティック制御のための組成物および方法 | |
| EP4288088A2 (en) | Lymphocyte activation gene 3 (lag3) compositions and methods for immunotherapy | |
| JP7541100B2 (ja) | siRNAおよびその用途 | |
| Habib et al. | Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment | |
| JP2011188849A (ja) | 抗腫瘍効果を有するmiR−7発現プラスミド | |
| WO2023019185A1 (en) | Compositions and methods for engineering stable tregs | |
| WO2023028471A1 (en) | Programmed cell death protein 1 (pd1) compositions and methods for cell-based therapy | |
| von Niessen | Optimization of RNA cancer vaccines using 3’UTR sequences selected for stabilization of RNA Dissertation zur Erlangung des Grades Doktor der Naturwissenschaften | |
| HK40032638A (en) | Polynucleotides, compositions, and methods for genome editing | |
| EA053115B1 (ru) | Полинуклеотиды, композиции и способы редактирования генома |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11 | Administrative time limit extension requested |
Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |